Deciphera Pharmaceuticals
Présence
Deciphera Pharmaceuticals fait partie des...
Deciphera Pharmaceuticals est une société cotée sous le symbole boursier DCPH (US).
Dirigeants
Voir l'organigramme avec ses 23 principaux dirigeants
Biographies les plus recherchées chez Deciphera Pharmaceuticals
- Steven Hoerter, Director, President and Chief Executive Officer
- John Martin, Director
- James Bristol, Chairman of the Board
Changements de dirigeants chez Deciphera Pharmaceuticals
- Daniel Flynn, qui est Executive Vice President and Chief Scientific Officer, part en retraite (publié le 4 août 2023).
- Dashyant Dhanak, a rejoint l'entreprise comme Executive Vice President and Chief Scientific Officer (publié le 4 août 2023).
Créer une alerte
pour suivre les mouvements de dirigeants chez Deciphera Pharmaceuticals.
Pharmacie
Deciphera Pharmaceuticals a 1 865 concurrents dont Pfizer (Etats—Unis), Sanofi (France) et Johnson & Johnson (Etats—Unis).
Actualités en fusion/acquisition en Pharmacie.
- AstraZeneca has announced the acquisition of Fusion Pharma (publié le 23 mars 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publié le 19 mars 2024).
- Frontier Medicines vient d'annoncer une levée de fonds de 80 millions de dollars. (publié le 27 février 2024).
Contacts en Pharmacie
Actualités
Derniers communiqués de presse par Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Appoints Kelley Dealhoy as Chief Business Officer | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. to Participate in Upcoming Investor Conferences | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 4, 2022 | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Pre-funded Warrants | Deciphera Pharmaceuticals, Inc.
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Deciphera Pharmaceuticals
- Deciphera Pharmaceuticals sur Wikipédia, Google News & Yahoo Finance en 1-click
- Deciphera Pharmaceuticals sur LinkedIn, Twitter & YouTube en 1-click
